We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Uniqure NV | TG:UQ1 | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.285 | 1.99% | 14.595 | 14.33 | 14.685 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 14.595 | 14.595 | 14.595 | 70 | 12:32:49 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 08/1/2025 | 12:05 | UKREG | uniQure Announces Pricing of its Public Offering |
| 07/1/2025 | 21:49 | UKREG | uniQure Announces Proposed Public Offering |
| 10/12/2024 | 12:05 | UKREG | uniQure Announces Alignment with FDA on Key Elements of Accelerated.. |
| 21/11/2024 | 12:05 | UKREG | uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical.. |
| 05/11/2024 | 12:05 | UKREG | uniQure Announces Third Quarter 2024 Financial Results and Highlights.. |
| 15/10/2024 | 11:05 | UKREG | uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of.. |
| 23/9/2024 | 11:05 | UKREG | uniQure Announces Orphan Drug Designation Granted to AMT-191 for the.. |
| 15/8/2024 | 11:05 | UKREG | uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of.. |
| 01/8/2024 | 11:05 | UKREG | uniQure Announces Second Quarter 2024 Financial Results and Provides.. |
| 23/7/2024 | 11:05 | UKREG | uniQure Announces Closing of Sale of Manufacturing Facility to Genezen |
1 Year Uniqure NV Chart |
Intraday Uniqure NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
